Saranraj Kamaraj MBBS MDAmit Agrawal Amit Korgaonkar Dr Arpit Jain Santosh Jagtap To view or add a comment, sign in Emerging evidence shows that when people stop taking GLP-1 weight-loss drugs, weight often returns and cardiometabolic risks may resurface, highlighting the importance of long-term strategies that pair medication with sustainable lifestyle and care support
TS: Data curation, Formal analysis, Investigation, Methodology, Resources, Software, Visualization, Writing original draft, Writing review & editing
Tirzepatide, on the other hand, combines the actions of two hormones to improve blood sugar control and promote weight loss
The experience of infertility: a review of recent literature
Applying barrier creams or antifungal powders
Wei P, He M, Wang Y, Han G